SEC FORM 4
$268,938.61
UNITED THERAPEUTICS Corp (UTHR)
Sale of 485 shares at $554.5126 per share.
Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S
Traded Oct 7, 2026 · Disclosed Oct 8, 2026
Source: SEC Form 4 · 0001106578-26-000159 · filed 2026-10-08 · View filing →